Page 24 - Read Online
P. 24

Sawabata et al. J Cancer Metastasis Treat 2017;3:16-20                              Journal of
           DOI: 10.20517/2394-4722.2016.67
                                                             Cancer Metastasis and Treatment

                                                                                               www.jcmtjournal.com
            Topic: Circulating Tumor Cells: Diagnostics and Clinical Applications               Open Access


           Lung cancer biopsy dislodges tumor cells

           into circulating blood



           Noriyoshi Sawabata, Tomotaka Kitamura, Yuko Nitta, Tomoyo Taketa, Takeshi Ohno, Tatsuya Fukumori,
           Takeru Hyakutake, Takahito Nakamura
           Division of General Thoracic Surgery, Respiratory Center, Hoshigaoka Medical Center, Hirakata, Osaka 574-8511, Japan.

           Correspondence to: Dr. Noriyoshi Sawabata, Division of General Thoracic Surgery, Respiratory Center, Hoshigaoka Medical Center, 4-8-1
           Hoshigaoka, Hirakata, Osaka 574-8511, Japan. E-mail: nsawabata@hotmail.com

           How to cite this article: Sawabata N, Kitamura T, Nitta Y, Taketa T, Ohno T, Fukumori T, Hyakutake T, Nakamura T. Lung cancer biopsy dislodges
           tumor cells into circulating blood. J Cancer Metastasis Treat 2017;3:16-20.
                                         ABSTRACT
            Article history:              Aim: A “seed” of lung cancer metastasis is circulating tumor cells (CTCs), which may be
            Received: 15-11-2016          dislodged from a tumor during biopsy. This possibility was assessed among patients who
            Accepted: 12-01-2017          underwent  lung  tumor  biopsy  using  flexible  fiber-topic  bronchoscopy  (FFB).  Methods:
            Published: 23-01-2017         The  study  involved  six  patients  with  non-small  cell  lung  cancer  who  underwent  FFB
                                          biopsy to diagnose a lesion pathologically (5 males and 1 female, median age 63 years, 6
            Key words:                    adenocarcinomas, of 4 clinical-stage IA, 1 stage IB, and 1 stage IIIA), CTCs were extracted
            Lung cancer,                  from the peripheral vein blood at pre-FFB and at post-FFB using a size selection method.
            biopsy,                       Results: No tumor cell was detected at pre- and post-FFB was in three cases (50%); no
            circulating tumor cells       tumor cells were detected pre-FFB while CTCs were detected at post-FFB in two cases
                                          (33.3%); and CTCs were detected at pre-FFB with numerous CTCs detected at post-FFB in
                                          one case (17.7%). In addition, similar tendencies were observed in each analysis of single-
                                          cell and clustered-cell categories. Conclusion: These results suggest that a FFB biopsy of
                                          lung cancer may potentially dislodge CTCs from a tumor into the circulating peripheral
                                          blood.
           INTRODUCTION                                       cells through the needle tract.  According to a study
                                                                                         [2]
                                                              using extracted human lung lobe with cancer lesions,
           There are three principal  methods  to diagnose  a   cancer cells were detected at a rate of 10% in the saline
           pulmonary  lung cancer region pathologically.  One   used to  wash the  pulmonary lobe surface. This  rate
           is  trans-bronchial  biopsy  (TBB)  using  flexible  fiber-  increased  to 60% after  FNAC.  In a clinical  setting.
                                                                                          [2]
           topic bronchoscopy (FFB)  and others are computed   it has been reported that the rate of relapse (pleural
           tomography (CT), guided fine needle aspiration biopsy   recurrence) was higher in an FNAC group than in a
           (FNAC), and surgical  resection.  Each method is   control group among surgical lung cancer cases. [3,4]
                                         [1]
           effective but has some weak points.                In addition, there has been  a recommendation  use
                                                              caution in employing FNAC as a method of lung cancer
           First,  FNAC has  the  potential  to  disseminate cancer   diagnosis based on evidence. [5]

                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

            16                                                                                                                                © 2017 OAE Publishing Inc.  www.oaepublish.com
   19   20   21   22   23   24   25   26   27   28   29